1. Home
  2. OKYO vs CPSH Comparison

OKYO vs CPSH Comparison

Compare OKYO & CPSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

SELL

Current Price

$1.09

Market Cap

78.2M

Sector

Health Care

ML Signal

SELL

Logo CPS Technologies Corp.

CPSH

CPS Technologies Corp.

SELL

Current Price

$3.17

Market Cap

90.8M

ML Signal

SELL

Company Overview

Basic Information
Metric
OKYO
CPSH
Founded
2007
1984
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Building Materials
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
78.2M
90.8M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
OKYO
CPSH
Price
$1.09
$3.17
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $8.33
N/A
AVG Volume (30 Days)
★ 282.3K
172.6K
Earning Date
07-20-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 113.64
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$0.29
Revenue Next Year
N/A
$6.79
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$3.04
52 Week High
$3.20
$14.39

Technical Indicators

Market Signals
Indicator
OKYO
CPSH
Relative Strength Index (RSI) 33.79 34.84
Support Level N/A N/A
Resistance Level $1.70 $4.77
Average True Range (ATR) 0.13 0.35
MACD -0.03 -0.07
Stochastic Oscillator 20.23 3.79

Price Performance

Historical Comparison
OKYO
CPSH

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases. It is advancing a pipeline designed to improve outcomes for patients suffering from debilitating ocular diseases that impact vision and ocular comfort. The company's main program, urcosimod, is being developed as a potential treatment for neuropathic corneal pain. Additionally, its development pipeline includes an exploratory candidate, OK-201, a non-opioid analgesic drug candidate, as a potential drug to treat acute and chronic ocular pain. The company has only one operating segment: the research and development of biotechnological and pharmaceutical products.

About CPSH CPS Technologies Corp.

CPS Technologies Corp designs, manufactures, and sells high-performance material solutions for customers across various markets, including transportation, energy, automotive, electronics, telecommunications, aerospace, and defense. The company develops and applies proprietary expertise in metal matrix composites (MMCs), which are engineered materials combining metals and ceramics to achieve enhanced performance properties. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers. The majority of the company's revenue is derived from the sale of its products in the United States of America.

Share on Social Networks: